Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GRAd COV2

Next Previous
Drug Profile

GRAd COV2

Alternative Names: Adenovirus-based COVID-19 vaccine; COVID-2019 vaccine - ReiThera; GRAd-COV2

Latest Information Update: 10 Apr 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ReiThera
  • Class COVID-19 vaccines; DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III COVID 2019 infections

Most Recent Events

  • 12 Jul 2021 The Independent Data Safety Monitoring Board and the Steering Committee recommends the continuation of the clinical development of GRAd COV2 following a recent review of the data and advances into phase III of the phase II/III COVITAR trial for COVID-2019 infections
  • 12 Jul 2021 Safety and immunogenicity data from the phase II/III COVITAR trial in COVID-2019 infections released by ReiThera
  • 19 May 2021 ReiThera completes Phase-I clinical trials in COVID-2019 infections (In volunteers) in Italy (IM, Injection) (NCT04528641)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top